FormWeb • idecabtagene vicleucel

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

idecabtagene vicleucel

idecabtagene vicleucel

Non-formulary Anti-Neoplastic

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Abecma	SUSPENSION, INTRAVENOUS	10 mL - 30 mL bag, 30 mL - 70 mL bag, 55 mL - 100 mL bag

Comments:

Prescribers should refer eligible patients to regional sites for ABECMA administration.

Reviewed: March 2022 (ABECMA)

Idecabtagene Viciencel (Abecma)

Last updated: Feb. 21, 2026

Black Box Warning: Cytokine Release Syndrome, Neurologic Toxicities, HLM/MAS and Prolonged Cytopenia and Secondary Hematological Malignancies

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.